delaware prescription opioid settlement distribution commission

The Prescription Opioid Settlement Distribution Commission narrowly approves new grant guidelines and procedures after an 8-month funding freeze.

After opioid settlement recipient Code Purple was flagged for misusing grant funds in June, the Prescription Opioid Settlement Distribution Commission decided to put all funding on hold until grant distribution procedures could be reviewed.

Delaware’s Prescription Opioid Settlement Fund continues to grow, but distribution of those funds will likely not resume until next year.

After months of anticipation, outside consulting agency Social Contract delivers its recommendations to the Prescription Opioid Settlement Distribution Commission on how it can better allocate funding.

Delaware’s opioid use continues to trend downward, but concerns around youth vaping and marijuana and alcohol use are on the rise.

An external report examining the Prescription Opioid Settlement Distribution Commission’s grant process is expected in October following fraud concerns.

Opioid settlement grant recipients await delayed funding amid mass audits and outside consultancy evaluations.

The governing body of the Prescription Opioid Settlement Distribution Commission is working to revamp its internal controls and grant distribution guidelines following a run-in with fraud concerns.

The State Auditor’s office releases a public Prescription Opioid Settlement Tracker amid a mass audit of grant recipients.

Delaware’s federal delegation secures $375,000 for youth substance use prevention amid statewide prescription opioid settlement grant freezes.